Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. Fadavi
Prognostic Value of Promoter Hypermethylation of Retinoic Acid Receptor Beta (RARB) and CDKN2 (P16/Mts1) in Prostate Cancer
Chinese Journal of Cancer Research
Cancer Research
Oncology
Related publications
The Prognostic Value of P16 Hypermethylation in Cancer: A Meta-Analysis
PLoS ONE
Multidisciplinary
Mutations of CDKN2 (MTS1/p16(INK4A)) and MTS2/p15(INK4B) Genes in Human Stomach, Hepatocellular, and Cholangio-Carcinomas
Experimental & Molecular Medicine
Biomarker Potential of ST6GALNAC3 and ZNF660 Promoter Hypermethylation in Prostate Cancer Tissue and Liquid Biopsies
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Functional Interactions Between Retinoic Acid Receptor-Related Orphan Nuclear Receptor (RORα) and the Retinoic Acid Receptors in the Regulation of the γF-Crystallin Promoter
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Prostate Cancer Genomic Signature Offers Prognostic Value
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
Figure 3: Hypermethylation of TNFRSF10C and Its Prognostic Value.
Specificity of a Retinoic Acid Response Element in the Phosphoenolpyruvate Carboxykinase Gene Promoter: Consequences of Both Retinoic Acid and Thyroid Hormone Receptor Binding.:
Molecular and Cellular Biology
Cell Biology
Molecular Biology
LRAT Promoter Hypermethylation as a Prognostic Marker for Colorectal Cancer Impairs Retinol Metabolism
Journal of Clinical Gastroenterology and Treatment
The AF-2 Region of the Retinoic Acid Receptor Α Mediates Retinoic Acid Inhibition of Estrogen Receptor Function in Breast Cancer Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
